MEX3A and cancer: The results of the independent sample t-test revealed significant differences in the expression of mex3a between cancer tissues and adjacent normal tissues and this result led us to evaluate whether mex3a was a biomarker of BLCA and whether mex3a could affect the overall survival of BLCA patients.